Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07220720 · ClinicalTrials.gov registry record · Phase 2

POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions

A Phase 2 study of Prostate, sponsored by University of Florida.

Active
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT07220720 is a Phase 2 study of Prostate that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 30 participants, below the 350-participant average among 5 other Prostate trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07220720, a Phase 2 study of Prostate, is active but no longer recruiting, sponsored by University of Florida.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this study to determine if using the (18)F-rhPSMA-7.3 PET-CT scan can improve the ability to spot serious prostate cancer in patients who have uncertain MRI results. These uncertain results include MRI results that showed a PIRADS 2 or PIRADS 3 area on the prostate. The investigators want to find out if this new test is better to detect prostate cancer than just doing a biopsy based on MRI alone.

Conditions Studied

Prostate

Interventions

  • DRUG Flotufolastat F 18

Study Locations (1)

Florida

  • UF Health - Jacksonville - Jacksonville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-11-04
Est. Completion 2032-11-15
Phase Phase 2

Sponsor

University of Florida

1,106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07220720

The ClinicalTrials.gov registry entry for NCT07220720 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 350-participant average among 5 other Prostate trials with a reported enrollment target (91% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate appearing as the primary indexed condition, and to 1 intervention - of which Flotufolastat F 18 is the first listed.

NCT07220720 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07220720 about?

NCT07220720 is a clinical study titled "POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions". The goal of this study to determine if using the (18)F-rhPSMA-7.3 PET-CT scan can improve the ability to spot serious prostate cancer in patients who have uncertain MRI results. These uncertain results include MRI results that showed a PIRADS 2 or PIRADS 3 area on the prostate. The investigators wan...

What is the current status of trial NCT07220720?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2025-11-04. Estimated completion is 2032-11-15.

What conditions does trial NCT07220720 study?

This clinical trial studies the following conditions: Prostate.

What interventions are being tested in trial NCT07220720?

The interventions under investigation include: Flotufolastat F 18 (DRUG).

Who is sponsoring clinical trial NCT07220720?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07220720 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.